The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of Pear Therapeutics, Inc. and its affiliate on April 12, 2023. The affiliates include Pear Therapeutics (US) Inc. The cases would be jointly administered for administrative and procedural purposes. Pear Therapeutics, Inc. has been designated as the lead debtor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
Mar. 22 | Disclosure Statement and Plan Approved on Interim Basis for Pear Therapeutics, Inc. | CI |
Mar. 04 | Combined Liquidation Plan and Disclosure Statement Filed by Pear Therapeutics, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 142 | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PEARQ Stock
- News Pear Therapeutics, Inc.
- Motion for Joint Administration Approved for Pear Therapeutics, Inc.